Tozaro is a biotech company leveraging molecular modelling and machine learning (ML) to design and develop stable and cost-effective polymers that bind to gene therapy vectors specifically & selectively. The Smart Polymer™ platform utilises >500 chemical groups to develop specific binding compounds, compared to traditional technologies using proteins and peptides, which use ca. 20 amino acids. Tozaro is able to mine a huge new chemical space using cost-effective Smart Polymers™
- Health
- Bedfordshire, United Kingdom
- £6m
- tozaro.com
- Update Information
More venture news
- 29 Jul 2026

MiraeMirae lands £4m in funding from Oxford Science Enterprises for conversational AI platform that tracks autoimmune disease between clinic visits
EquityHealth - 28 Jul 2026

DITTODITTO lands a £4.5m seed round led by FoodLabs to develop evidence-based menstrual health supplements
SeedHealth - 24 Jul 2026

TidalSenseTidalSense secures £14m in funding from VCs to roll out AI-driven breath test for lung disease
EquityHealth
